Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacira Pharmaceuticals

25.97
-0.7700-2.88%
Post-market: 25.970.00000.00%19:42 EDT
Volume:431.59K
Turnover:11.33M
Market Cap:1.20B
PE:-11.45
High:27.18
Open:26.68
Low:25.95
Close:26.74
Loading ...
Sep 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]